Filing Details
- Accession Number:
- 0001144204-15-028941
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-08 21:00:14
- Reporting Period:
- 2015-05-06
- Filing Date:
- 2015-05-08
- Accepted Time:
- 2015-05-08 21:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559512 | Luciano Adorini | C/O Intercept Pharmaceuticals, Inc. 450 W. 15Th Street, Suite 505 New York NY 10011 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-06 | 4,000 | $8.67 | 14,060 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-06 | 1,800 | $259.12 | 12,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-05-06 | 1,000 | $260.00 | 11,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-05-06 | 1,000 | $261.05 | 10,260 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-05-06 | 200 | $262.00 | 10,060 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Disposition | 2015-05-06 | 4,000 | $0.00 | 4,000 | $8.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-09-06 | No | 4 | M | Direct |
Footnotes
- The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on March 9, 2015.
- All the shares underlying this option have fully vested.
- This transaction was executed in multiple trades at prices ranging from $259.00 to $259.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $261.00 to $261.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
